AMY GILBERT: Open Payments
NPI 1780461681 · PLYMOUTH, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,517 in 19 payments from 9 companies in 2025. Trend: 2023 $145 · 2024 $1,819 · 2025 $5,517
Speaker / faculty: $3,322Travel & lodging: $1,868Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $5,293 |
| Celgene Corporation | 2 | $46 |
| Biogen, Inc. | 2 | $41 |
| Octapharma USA, Inc. | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Amgen Inc. | 1 | $21 |
| Pharming Healthcare, Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $17 |
| CSL Behring | 1 | $15 |
Products named: ZEPOSIA, OCTAGAM IMMUNE GLOBULIN (HUMAN), KESIMPTA, VUMERITY, UPLIZNA, TYSABRI, RUCONEST, Ocrevus Zunovo.
Industry payments across MN — which companies pay providers there.
